After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?

DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Primary tabs

Honore P. Crit Care Med 2023.pdf

Honoré, Patrick [UCL] Redant, Sebastien Djimafo, Pharan Blackman, Sydney Bousbiat, Ibrahim Attou, Rachid et al.[show all]

Document type	Article de périodique (Journal article) – Article de recherche
Access type	Accès libre
Publication date	2023
Language	Anglais
Journal information	"Critical care medicine" - Vol. 51, no.2, p. e68-e69 (2023)
Peer reviewed	yes
e-issn	1530-0293
Publication status	Publié
Affiliations	UCL - SSS/IREC/MONT - Pôle Mont Godinne UCL - (MGD) Services des soins intensifs
MESH Subject	Humans ; Shock, Septic ; Vasopressins ; Acute Kidney Injury ; Vasoconstrictor Agents ; Norepinephrine
Links	https://www.ncbi.nlm.nih.gov/pubmed/36661471[Pubmed] https://doi.org/10.1097/CCM.0000000000005725[DOI] http://hdl.handle.net/2078.1/282129[Handle]

Bibliographic reference	Honoré, Patrick ; Redant, Sebastien ; Djimafo, Pharan ; Blackman, Sydney ; Bousbiat, Ibrahim ; et. al. After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?. In: Critical care medicine, Vol. 51, no.2, p. e68-e69 (2023)
Permanent URL	http://hdl.handle.net/2078.1/282129